Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Siga will collaborate with Ludwig Institute to develop cancer vaccines

Oct. 15, 1998

CEA-Cide receives orphan drug designation

Oct. 14, 1998

Demegen receives patent protection for Peptidyl MIMs in cancer indications

Oct. 14, 1998

U.S. patent covers protegrins and synthetic analogues such as IntraBiotics' IB-367

Oct. 14, 1998

Bicyclic inhibitors of protein farnesyltransferase for cancer, restenosis, etc.

Oct. 14, 1998

Novel series of inhibitors of protein farnesyltransferase developed at RPR

Oct. 14, 1998

Introgen acquires option to license Bak gene from LXR

Oct. 14, 1998

Hybridon advances antisense drug to phase II

Oct. 14, 1998

Aphton initiates phase I/II trial of Gonadimmune in prostate cancer patients

Oct. 14, 1998

Disappointing results of pilot study of SDZ-PSC-833 + doxorubicin in colorectal cancer

Oct. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...